Sponsor: NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH UNIVERSITY OF HAWAII
This project utilizes a combination of established and new preclinical models of ovarian cancer to evaluate the therapeutic efficacy of continuous low-dose chemotherapy. The role of Snail protein in rendering ovarian cancers less responsive chemotherapeutic agents will also be examined.
Posting date: Wed, 03/29/2017
Award start date: Fri, 07/01/2016
Award end date: Fri, 06/30/2017
